Insider Holders & Insider Ownership - BeiGene Ltd. (BGNE)

List of insiders holdings for BeiGene Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 BAKER BROS. ADVISORS LP
14159 L.P.
Baker Bros. Advisors (GP) LLC
BAKER JULIAN
BAKER FELIX
667 L.P.
Baker Brothers Life Sciences LP
Director
10% Owner		 2024-12-10 21:30:34 125,276,610
0		 125,276,610 Form 13D
2 HHLR ADVISORS LTD.
HILLHOUSE INVESTMENT MANAGEMENT LTD.
10% Owner		 2025-03-03 21:30:19 92,805,741
0		 92,805,741 Form 13D
3 OYLER JOHN
Chief Executive Officer		 2025-03-12 17:02:56 4,055,422
46,055,316		 50,110,738 Form 4
4 CB Biotech Investment Ltd
CPEChina Fund L.P.
CITIC PE Associates L.P.
CITIC PE Funds Ltd
10% Owner		 2016-02-09 20:07:35 19,601,138
0		 19,601,138 Form 4
5 AMGEN INC
10% Owner		 2021-09-13 19:27:07 18,943,802
0		 18,943,802 Form 4
6 Wang Xiaodong
Chair, Scientific Advisory Brd		 2025-04-16 17:12:21 6,167,932
4,978,213		 11,146,145 Form 4
7 BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director		 2025-02-28 21:28:25 20,838
8,320,605		 8,341,443 Form 4
8 Glazer Donald W.
Director		 2024-06-07 16:58:01 2,752,615
0		 2,752,615 Form 4
9 Li Ji
EVP and Gl. Head of Bus. Dev.		 2018-03-02 18:41:22 2,721,000
0		 2,721,000 Form 4
10 Peterson Amy C.
CMO, Immuno-oncology		 2018-12-19 18:34:10 1,966,402
0		 1,966,402 Form 4
11 Wang Lai
Global Head of R&D		 2025-03-07 19:22:33 990,171
731,965		 1,722,136 Form 4
12 Liang Howard
CFO & Chief Strategy Officer		 2021-06-30 16:45:49 1,553,149
0		 1,553,149 Form 4
13 Wu Xiaobin
President, COO & GM China		 2025-04-03 17:04:54 1,484,482
4,000		 1,488,482 Form 4
14 Yang Jianxin
Sr. VP, Head of Clinical Dev.		 2016-07-15 16:34:25 825,000
0		 825,000 Form 4
15 Yan Wendy Xiaojun
Sr. VP, Head of Reg. Affairs		 2016-07-15 16:30:50 825,000
0		 825,000 Form 4
16 Wang Julia Aijun
Chief Financial Officer		 2024-07-03 17:05:32 426,595
0		 426,595 Form 4
17 Huang Jane
CMO, Hematology		 2021-12-16 17:50:15 371,331
0		 371,331 Form 4
18 Lee Chan Henry
SVP, General Counsel		 2025-03-07 19:20:50 246,142
0		 246,142 Form 4
19 Tang Ke
Director		 2017-04-21 16:42:20 199,992
0		 199,992 Form 4
20 Rosenberg Aaron
Chief Financial Officer		 2025-03-07 19:19:40 167,128
0		 167,128 Form 4
21 Yuan RuiRong
Chief Medical Officer		 2016-02-09 20:08:35 130,000
0		 130,000 Form 4
22 Malley Thomas
Director		 2023-06-20 19:00:29 103,671
0		 103,671 Form 4
23 HOOPER ANTHONY C
Director		 2024-06-07 17:00:40 87,906
0		 87,906 Form 4
24 Sanders Corazon (Corsee) D.
Director		 2024-06-07 16:55:28 80,392
0		 80,392 Form 4
25 Yi Qingqing
Director		 2024-06-07 16:31:17 80,106
0		 80,106 Form 4
26 Dugan Margaret
Director		 2024-06-07 17:02:26 80,106
0		 80,106 Form 4
27 Riva Alessandro
Director		 2024-06-07 16:57:19 80,106
0		 80,106 Form 4
28 BRANDICOURT OLIVIER
Director		 2024-06-07 17:01:38 50,492
0		 50,492 Form 4
29 Ball Titus B.
Principal Accounting Officer		 2024-09-05 17:40:30 46,124
0		 46,124 Form 4
30 Sharp Shalini
Director		 2024-10-02 19:21:19 25,389
0		 25,389 Form 4
31 Chen Timothy Yung-Cheng
Director		 2021-06-21 16:42:08 25,298
0		 25,298 Form 4
32 su Jingshyh S
Director		 2021-06-21 16:34:12 25,298
0		 25,298 Form 4
33 KRISHANA RANJEEV
Director		 2016-02-02 19:14:15 0
0		 0 Form 3
34 Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research GmbH
10% Owner		 2018-02-13 16:29:07 0
0		 0 Form 13G
35 GOLLER MICHAEL
Director		 2016-02-02 19:40:27 0
0		 0 Form 3